EUVIMEDEUVIMED entdecken
Open Access

Alamandine inhibits pathological retinal neovascularization by targeting the MrgD-mediated HIF-1α/VEGF pathway

Kun Zhao, Yaping Jiang, Wen Huang, Yukang Mao, Yihui Chen, Peng Li, Chuanxi Yang

Journal of Zhejiang University-SCIENCE B · 2025

DOI: 10.1631/jzus.b2500154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Zhejiang University-SCIENCE B, 2025. Verfasst von Kun Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. Hauptthemen laut MEDLINE: Retinal Neovascularization, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1, alpha Subunit, Oligopeptides. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the National Natural Science Foundation of China, the Shanghai Sailing Program, the Academy Talent Special Fund of The First Affiliated Hospital of Nanjing Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal NeovascularizationVascular Endothelial Growth Factor AHypoxia-Inducible Factor 1, alpha SubunitOligopeptidesAnimalsMice, Inbred C57BLHumansMiceSignal TransductionCell ProliferationEndothelial CellsRetinopathy of PrematurityApoptosisCell MovementRenin-Angiotensin SystemCells, Cultured

Stichwörter der Autor:innen

AlamandineMas-related G protein-coupled receptor D (MrgD)Oxygen-induced retinopathy (OIR)Pathological neovascularizationRetinopathy of prematurity (ROP)Vascular endothelial growth factor (VEGF)

Substanzen

Vascular Endothelial Growth Factor AHypoxia-Inducible Factor 1, alpha SubunitOligopeptidesalamandine

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Department of Ophthalmology, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200082, China.
  • Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou 215000, China.
  • Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. lipeng198610@163.com.
  • Department of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200082, China. lipeng198610@163.com, 2205515@tongji.edu.cn.

Förderung

  • the National Natural Science Foundation of China
  • the Shanghai Sailing Program
  • the Academy Talent Special Fund of The First Affiliated Hospital of Nanjing Medical University
  • the Jiangsu Funding Program for Excellent Postdoctoral Talent

Zitieren

APA

Zhao, K., Jiang, Y., Huang, W., Mao, Y., Chen, Y., Li, P., & Yang, C. (2025). Alamandine inhibits pathological retinal neovascularization by targeting the MrgD-mediated HIF-1α/VEGF pathway. Journal of Zhejiang University-SCIENCE B. https://doi.org/10.1631/jzus.b2500154

Vancouver

Zhao K, Jiang Y, Huang W, Mao Y, Chen Y, Li P, et al. Alamandine inhibits pathological retinal neovascularization by targeting the MrgD-mediated HIF-1α/VEGF pathway. Journal of Zhejiang University-SCIENCE B. 2025. doi:10.1631/jzus.b2500154

BibTeX
@article{Zhao2025,
  author = {Zhao, Kun and Jiang, Yaping and Huang, Wen and Mao, Yukang and Chen, Yihui and Li, Peng and Yang, Chuanxi},
  title = {Alamandine inhibits pathological retinal neovascularization by targeting the MrgD-mediated HIF-1α/VEGF pathway},
  journal = {Journal of Zhejiang University-SCIENCE B},
  year = {2025},
  doi = {10.1631/jzus.b2500154}
}
Kostenlos starten →